Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Aug;82(2):594–600. doi: 10.1172/JCI113637

Complement induces a transient increase in membrane permeability in unlysed erythrocytes.

J A Halperin 1, A Nicholson-Weller 1, C Brugnara 1, D C Tosteson 1
PMCID: PMC303553  PMID: 3403718

Abstract

The effects of low concentrations of human serum on antibody-sensitized sheep erythrocytes (EA) were studied. We report that exposure to low concentrations of serum induced a large but transient increase in the membrane permeability of those EA that do not lyse. This change in the permeability of the erythrocyte membrane resulted in net uptake of Na+ and decrease in cell K+, without affecting the total internal cation content. Although exposure to serum also allowed for net uptake of larger molecules like L-glucose, it did not lead to cell swelling. Experiments with sera genetically deficient in one of the terminal complement components showed that C8, but not C9, was required to produce the observed change in membrane permeability. Therefore, we propose that the C5b-8 complex can mediate the transient increase in permeability observed in unlysed erythrocytes during complement activation by whole serum.

Full text

PDF
594

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhakdi S., Tranum-Jensen J. Molecular nature of the complement lesion. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5655–5659. doi: 10.1073/pnas.75.11.5655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boyle M. D., Borsos T. Studies on the terminal stages of immune hemolysis. V. Evidence that not all complement-produced transmembrane channels are equal. J Immunol. 1979 Jul;123(1):71–76. [PubMed] [Google Scholar]
  3. Brugnara C., Tosteson D. C. Cell volume, K transport, and cell density in human erythrocytes. Am J Physiol. 1987 Mar;252(3 Pt 1):C269–C276. doi: 10.1152/ajpcell.1987.252.3.C269. [DOI] [PubMed] [Google Scholar]
  4. Campbell A. K., Morgan B. P. Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack. Nature. 1985 Sep 12;317(6033):164–166. doi: 10.1038/317164a0. [DOI] [PubMed] [Google Scholar]
  5. Carney D. F., Koski C. L., Shin M. L. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9. J Immunol. 1985 Mar;134(3):1804–1809. [PubMed] [Google Scholar]
  6. DANON D., MARIKOVSKY V. DETERMINATION OF DENSITY DISTRIBUTION OF RED CELL POPULATION. J Lab Clin Med. 1964 Oct;64:668–674. [PubMed] [Google Scholar]
  7. Densen P., Brown E. J., O'Neill G. J., Tedesco F., Clark R. A., Frank M. M., Webb D., Myers J. Inherited deficiency of C8 in a patient with recurrent meningococcal infections: further evidence for a dysfunctional C8 molecule and nonlinkage to the HLA system. J Clin Immunol. 1983 Jan;3(1):90–99. doi: 10.1007/BF00919144. [DOI] [PubMed] [Google Scholar]
  8. Ferreira H. G., Lew V. L. Use of ionophore A23187 to measure cytoplasmic Ca buffering and activation of the Ca pump by internal Ca. Nature. 1976 Jan 1;259(5538):47–49. doi: 10.1038/259047a0. [DOI] [PubMed] [Google Scholar]
  9. GREEN H., BARROW P., GOLDBERG B. Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes. J Exp Med. 1959 Nov 1;110:699–713. doi: 10.1084/jem.110.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gee A. P., Boyle M. D., Borsos T. Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release. J Immunol. 1980 Apr;124(4):1905–1910. [PubMed] [Google Scholar]
  11. Kitamura H., Nagaki K. Inhibitory effect of sugars on the spontaneous lysis of EAC1-8. Mol Immunol. 1981 Nov;18(11):985–990. doi: 10.1016/0161-5890(81)90116-4. [DOI] [PubMed] [Google Scholar]
  12. Koski C. L., Ramm L. E., Hammer C. H., Mayer M. M., Shin M. L. Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3816–3820. doi: 10.1073/pnas.80.12.3816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lachmann P. J., Thompson R. A. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med. 1970 Apr 1;131(4):643–657. doi: 10.1084/jem.131.4.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lint T. F., Zeitz H. J., Gewurz H. Inherited deficiency of the ninth component of complement in man. J Immunol. 1980 Nov;125(5):2252–2257. [PubMed] [Google Scholar]
  15. Mayer M. M., Hammer C. H., Michaels D. W., Shin M. L. Immunologically mediated membrane damage: the mechanism of complement action and the similarity of lymphocyte-mediated cytoxicity. Immunochemistry. 1978 Nov;15(10-11):813–831. doi: 10.1016/0161-5890(78)90115-3. [DOI] [PubMed] [Google Scholar]
  16. Medof M. E., Kinoshita T., Nussenzweig V. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med. 1984 Nov 1;160(5):1558–1578. doi: 10.1084/jem.160.5.1558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Michaels D. W., Abramovitz A. S., Hammer C. H., Mayer M. M. Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complement. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2852–2856. doi: 10.1073/pnas.73.8.2852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morgan B. P., Dankert J. R., Esser A. F. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. J Immunol. 1987 Jan 1;138(1):246–253. [PubMed] [Google Scholar]
  19. Morgan B. P., Luzio J. P., Campbell A. K. Intracellular Ca2+ and cell injury: a paradoxical role of Ca2+ in complement membrane attack. Cell Calcium. 1986 Dec;7(5-6):399–411. doi: 10.1016/0143-4160(86)90042-4. [DOI] [PubMed] [Google Scholar]
  20. Müller-Eberhard H. J. Transmembrane channel-formation by five complement proteins. Biochem Soc Symp. 1985;50:235–246. [PubMed] [Google Scholar]
  21. Nicholson-Weller A., Burge J., Fearon D. T., Weller P. F., Austen K. F. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol. 1982 Jul;129(1):184–189. [PubMed] [Google Scholar]
  22. Ohanian S. H., Schlager S. I. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense. Crit Rev Immunol. 1981 Jan;1(3):165–209. [PubMed] [Google Scholar]
  23. Pangburn M. K., Schreiber R. D., Müller-Eberhard H. J. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5430–5434. doi: 10.1073/pnas.80.17.5430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ramm L. E., Mayer M. M. Life-span and size of the trans-membrane channel formed by large doses of complement. J Immunol. 1980 May;124(5):2281–2287. [PubMed] [Google Scholar]
  25. Ramm L. E., Whitlow M. B., Koski C. L., Shin M. L., Mayer M. M. Elimination of complement channels from the plasma membranes of U937, a nucleated mammalian cell line: temperature dependence of the elimination rate. J Immunol. 1983 Sep;131(3):1411–1415. [PubMed] [Google Scholar]
  26. Ramm L. E., Whitlow M. B., Mayer M. M. Size of the transmembrane channels produced by complement proteins C5b-8. J Immunol. 1982 Sep;129(3):1143–1146. [PubMed] [Google Scholar]
  27. Salama A., Bhakdi S., Mueller-Eckhardt C., Kayser W. Deposition of the terminal C5b-9 complement complex on erythrocytes by human red cell autoantibodies. Br J Haematol. 1983 Sep;55(1):161–169. doi: 10.1111/j.1365-2141.1983.tb01234.x. [DOI] [PubMed] [Google Scholar]
  28. Schönermark S., Rauterberg E. W., Shin M. L., Löke S., Roelcke D., Hänsch G. M. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor. J Immunol. 1986 Mar 1;136(5):1772–1776. [PubMed] [Google Scholar]
  29. Sims P. J., Wiedmer T. Repolarization of the membrane potential of blood platelets after complement damage: evidence for a Ca++ -dependent exocytotic elimination of C5b-9 pores. Blood. 1986 Aug;68(2):556–561. [PubMed] [Google Scholar]
  30. Stolfi R. L. Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system. J Immunol. 1968 Jan;100(1):46–54. [PubMed] [Google Scholar]
  31. Suttorp N., Seeger W., Zinsky S., Bhakdi S. Complement complex C5b-8 induces PGI2 formation in cultured endothelial cells. Am J Physiol. 1987 Jul;253(1 Pt 1):C13–C21. doi: 10.1152/ajpcell.1987.253.1.C13. [DOI] [PubMed] [Google Scholar]
  32. Szymanski I. O., Swanton R. E., Odgren P. R. Quantitation of the third component of complement on stored red cells. Transfusion. 1984 May-Jun;24(3):194–197. doi: 10.1046/j.1537-2995.1984.24384225019.x. [DOI] [PubMed] [Google Scholar]
  33. TOSTESON D. C., HOFFMAN J. F. Regulation of cell volume by active cation transport in high and low potassium sheep red cells. J Gen Physiol. 1960 Sep;44:169–194. doi: 10.1085/jgp.44.1.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tamura N., Shimada A., Chang S. Further evidence for immune cytolysis by antibody and the first eight components of complement in the absence of C9. Immunology. 1972 Jan;22(1):131–140. [PMC free article] [PubMed] [Google Scholar]
  35. Tedesco F., Densen P., Villa M. A., Petersen B. H., Sirchia G. Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules. J Clin Invest. 1983 Feb;71(2):183–191. doi: 10.1172/JCI110758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Thompson R. A., Lachmann P. J. Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J Exp Med. 1970 Apr 1;131(4):629–641. doi: 10.1084/jem.131.4.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tosteson M. T., Holmes S. J., Razin M., Tosteson D. C. Melittin lysis of red cells. J Membr Biol. 1985;87(1):35–44. doi: 10.1007/BF01870697. [DOI] [PubMed] [Google Scholar]
  38. Zalman L. S., Wood L. M., Müller-Eberhard H. J. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6975–6979. doi: 10.1073/pnas.83.18.6975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES